Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy

NCT00807261 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Gemcitabine and Docetaxel

Sponsor

Asan Medical Center

Collaborators

[object Object]
[object Object]
[object Object]